Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing

NCT05924256 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05924256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05924256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 26, 2023
Completion date
December 30, 2026
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced salivary gland carcinoma